certican ® 075 mg
novartis pharma stein ag. - everolimus - comprimido - 0,75 mg
glivec ® 400 mg
novartis pharma stein ag. - imatinib (eq. a 478 mg de mesilato de imatinib) - comprimido recubierto - 400 mg
afinitor® 25 mg
novartis pharma stein ag. - everolimus - comprimido - 2,5 mg
afinitor® 10 mg
novartis pharma stein ag. - everolimus - comprimido - 10 mg
afinitor® 5 mg
novartis pharma stein ag. - everolimus - comprimido - 5 mg
letrozol 25 mg
novartis pharma stein ag. - letrozol - comprimido recubierto - 2,5 mg
prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics
novartis vaccines and diagnostics s.r.l. - antígenos de superficie del virus de la gripe (hemaglutinina y neuraminidasa) de la cepa a / viet nam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vacunas - inmunización activa contra el subtipo h5n1 del virus influenza a. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.
cosentyx (secukinumab) 150 mg/ml solucion inyectable en jeringa prellenada
novartis de venezuela s.a. - secukinumab -
cosentyx (secukinumab) 150mg polvo liofilizado para solucion inyectabl
novartis de venezuela, s.a. - secukinumab -
signifor lar 20 mg polvo para suspension inyectable
novartis de venezuela, s.a. - pasireotida - polvo para suspension inyectable - 20 mg